Health Desk-07 Dec’18: The share of GlaxoSmithKline has started skyrocketing in the Dhaka bourse just after consumer goods giant Unilever announced to buy majority stakes of the GSK's health food and drinks business in Bangladesh.
The price of each of the British pharmaceutical company's share rose 51.75 percent or Tk 561 in the last nine trading sessions to reach Tk 1,645 on Thursday.
GSK Bangladesh announced on December 4 that it agreed to sell its nutrition business in the country to Unilever for Tk 1,640 crore, which was Tk 45 crore more than the market value of the company on the day.
Among the major sectors, energy and telecom rose 0.6 percent while engineering was down 0.1 percent. Prime Islami Life Insurance was the day's best performer with a 9.98 percent gain while Delta Spinners was the biggest loser, shedding 6.94 percent.